Genomics

Dataset Information

XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor KPT-335.


ABSTRACT: XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor KPT-335.

PROVIDER: PRJNA688482 | ENA |

REPOSITORIES: ENA